培美曲塞加铂类联合或不联合帕博利珠单抗对初治转移性非鳞状NSCLC患者的疗效与安全性分析:KEYNOTE-189研究方案指定的最终分析
D.RODRíGUEZ-ABREU;S.F.POWELL;M.J.HOCHMAIR;S.GADGEEL;E.ESTEBAN;E. FELIP;G.SPERANZA;F.De ANGELIS;M.DóMINE;S.Y.CHENG;H.G.BISCHOFF;N.PELED;M.RECK;R.HUI;E.B.GARON;M.BOYER;T.KURATA;J.YANG;M.C.PIETANZA;F.SOUZA;M.C.GARASSINO;周彩存-Medical Oncology, Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain;Oncology, Sanford Health, Sioux Falls, USA;Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria;Thoracic Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, USA;Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo;Medical Oncology Department, Vall d'Hebron University, Vall d'Hebron Institute of Oncology (VHIO),Barcelona, Spain;Centre Integré de Cancérologie de la Montérégie, H?pital Charles-Le Moyne, Greenfield Park, Canada;Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz,Ⅱs-FJD, Madrid, Spain;Sunnybrook Health Sciences Centre,Toronto, Canada;Thoraxklinik, Heidelberg, Germany;Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel;Lungen Clinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany;Department of Medical Oncology, Westmead Hospital and University of Sydney, Sydney, Australia;Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, USA;Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, Australia;Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan;Merck & Co., Inc., Kenilworth, USA;Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;University of Chicago Medicine & Biological Sciences, Knapp Center for Biomedical Discovery, Chicago, USA;同济大学附属上海市肺科医院肿瘤科,上海 200433
